Sp1291a

GI PCR PANELS: HOW TO UTILIZE MOLECULAR SYNDROMIC TESTING IN YOUR PRACTICE

Date
May 9, 2023

Society: DDW

Join us as we dive deep into rapid multi-pathogen diagnostic testing. We'll discuss use cases, how to interpret syndromic testing data, and how this data can positively impact clinical decision making. Learn how syndromic testing can do more, faster. Sponsored by bioMérieux

Presenter

Speaker Image for Jordan Axelrad
NYU Langone Health

Tracks

Related Products

Thumbnail for CLINICAL AND PSYCHOSOCIAL RESPONSE ARE ASSOCIATED WITH IMPROVED SEXUAL DYSFUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGIC THERAPY
CLINICAL AND PSYCHOSOCIAL RESPONSE ARE ASSOCIATED WITH IMPROVED SEXUAL DYSFUNCTION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGIC THERAPY
Background: Patients with inflammatory bowel disease (IBD) often modify their diet in attempt to manage their disease and symptoms. In some cases, dietary changes involve excessive restriction, which may place patients at risk for adverse consequences…
Thumbnail for Microbial Therapies for GI Diseases, Probiotics and Synbiotics in Health and Disease
Microbial Therapies for GI Diseases, Probiotics and Synbiotics in Health and Disease
This session will explore the therapeutic potential of the gut microbiome in treating inflammatory bowel disease and gastrointestinal cancers…
Thumbnail for TOFACITINIB UPTAKE BY PATIENT-DERIVED INTESTINAL ORGANOIDS PREDICTS INDIVIDUAL CLINICAL RESPONSIVENESS
TOFACITINIB UPTAKE BY PATIENT-DERIVED INTESTINAL ORGANOIDS PREDICTS INDIVIDUAL CLINICAL RESPONSIVENESS
BACKGROUND: Despite increasing therapeutic options in the treatment of ulcerative colitis (UC), achieving disease remission remains a major clinical challenge. Nonresponse to therapy is common and clinicians have little guidance in selecting the optimal therapy for an individual patient…